US EditionPublished • loading... • Updated
Zepp Health Corporation Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
FinVolution's 2025 net profit rose 6.6% to RMB2.5 billion, driven by 41.4% international transaction volume growth despite tighter underwriting in China.
- In a Shanghai filing on March 18, 2026, FinVolution announced FY 2025 results, with net revenue of RMB3,023.9 million and net profit of RMB415.5 million.
- Facing recent regulatory changes in China, management said tighter underwriting reduced group net revenue impact as China transaction volume fell to RMB38.7 billion.
- Across overseas markets, international transaction volume in Q4 rose to RMB4.1 billion, with 3.8 million unique international borrowers and 31.4% of net revenue, the company said.
- Looking to 2026, FinVolution set revenue guidance at RMB11.5–12.9 billion, executed US$107.2 million in share repurchases, and increased dividend per ADS to US$0.306.
- Building on international expansion, FinVolution included an impairment of RMB50.7 million and increased provision for loans receivable last year, according to management.
Insights by Ground AI
92 Articles
92 Articles
Coverage Details
Total News Sources92
Leaning Left12Leaning Right5Center35Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 23%
C 67%
Factuality
To view factuality data please Upgrade to Premium
